OR WAIT null SECS
June 24, 2024
This alert follows a similar one from the European Medicines Agency in October 2023 amid a rise in demand for the diabetes medication that, in turn, created a shortage.
A new initiative will advance access to quality medicines and vaccines in Africa.
June 21, 2024
The transaction, announced June 20, follows Bora’s purchase of Minnesota-based Upsher-Smith Laboratories earlier in 2024.
June 20, 2024
Imfinzi (durvalumab) combined with chemotherapy decreased the risk of disease progression or death by 58% in a 700-patient trial.
The companies have completed the expansion and qualification phase and now enter a stand-by phase for five years.
June 19, 2024
The $58 million investment has resulted in a 72,000-square-foot facility with a dedicated LC–MS space and molecular suites and will bring as many as 350 new jobs onto the campus.
PRAC is reviewing the risk of secondary malignancies in patients treated with CAR T-cell medicines.
June 18, 2024
Yimmugo, which was introduced in Europe at the end of 2022, could be on the market in the US within months.
The research collaboration and licensing agreement will focus on the discovery and development of RNA exon editing therapeutics.
Nadia Sellami, PhD, global segment lead for gene and cell therapy at PacBio, talks about long-read sequencing for cell and gene editing in a video interview.